Bcl-2 reactivity was also seen in the chondromyxoid fibromas while the chondroblastomas were negative, indicating different paths of tumorogenesis for these two entities despite their superficial resemblance. This evidence concerns the gene BCL2 and chondromyxoid fibroma.